CRISTINA GABRIEL: Open Payments
NPI 1194000620 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,607 in 119 payments from 17 companies in 2025. Trend: 2023 $3,126 · 2024 $2,839 · 2025 $2,607
Food & beverage: $2,607
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $537 |
| Otsuka America Pharmaceutical, Inc. | 9 | $303 |
| E.R. Squibb & Sons, L.L.C. | 6 | $277 |
| Axsome Therapeutics, Inc. | 7 | $263 |
| Vanda Pharmaceuticals Inc. | 9 | $250 |
| Teva Pharmaceuticals USA, Inc. | 10 | $193 |
| Neurocrine BioSciences, Inc. | 5 | $121 |
| Lundbeck LLC | 5 | $117 |
| Phathom Pharmaceuticals, Inc. | 1 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $88 |
Products named: VRAYLAR, REXULTI, COBENFY, Auvelity, FANAPT, AUSTEDO XR, Sunosi, INGREZZA.
Industry payments across SC — which companies pay providers there.
